Company:PowderJect
From HandWiki
Revision as of 15:32, 6 June 2021 by imported>JTerm (linkage)
Short description: Pharmaceutical company in England (1993-2003)
PowderJect Pharmaceuticals was a British vaccine, drug and diagnostics delivery company founded by Brian Bellhouse. They developed a needle-free injection system for delivering medications and vaccines.
In 1993, PowderJect was spun out of the University of Oxford with the help of Isis Innovation.[1][2]
In 2003, the company was taken over by the American Chiron Corporation for £542 million.[3][4] The company's CEO was Paul Drayson, Baron Drayson, son-in-law of the founder, Brian Bellhouse, and they received £100 million following the takeover.[3][4] Drayson received £43m for his 8% holding, Bellhouse £19.5m for his 3.6% stake, and their family trusts received £41m.[4]
References
- ↑ Elliott, Francis (14 April 2002). "Labour donor is no stranger to controversy". Telegraph. https://www.telegraph.co.uk/news/uknews/1390813/Labour-donor-is-no-stranger-to-controversy.html. Retrieved 29 June 2017.
- ↑ Andrew Clark (19 January 2002). "Interview: Paul Drayson, Powderject Pharmaceuticals | Business". The Guardian. https://www.theguardian.com/business/2002/jan/19/2. Retrieved 29 June 2017.
- ↑ 3.0 3.1 Fletcher, Richard (27 April 2003). "PowderJect to be sold for £500m". Daily Telegraph (UK). https://www.telegraph.co.uk/finance/2850142/PowderJect-to-be-sold-for-500m.html. Retrieved 27 June 2017.
- ↑ 4.0 4.1 4.2 Geoffrey Gibbs (20 May 2003). "£43m windfall for PowderJect chief | Business". The Guardian. https://www.theguardian.com/business/2003/may/20/executivesalaries.executivepay1. Retrieved 27 June 2017.
![]() | Original source: https://en.wikipedia.org/wiki/PowderJect.
Read more |